

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.30920818 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 6.10294792 |
| 3 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.64017899 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.60637268 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23206662 |
| 6 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.99273549 |
| 7 | regulation of vitamin metabolic process (GO:0030656) | 4.60056360 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40251071 |
| 9 | positive regulation of type 2 immune response (GO:0002830) | 4.26091319 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.17184298 |
| 11 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.14984242 |
| 12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.13952621 |
| 13 | tolerance induction (GO:0002507) | 4.11360420 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10820578 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10820578 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10075036 |
| 17 | regulation of podosome assembly (GO:0071801) | 4.09784591 |
| 18 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.09183948 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.09141607 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04869506 |
| 21 | T-helper 1 type immune response (GO:0042088) | 4.01803381 |
| 22 | mature B cell differentiation involved in immune response (GO:0002313) | 4.00171446 |
| 23 | negative regulation of viral genome replication (GO:0045071) | 3.94244346 |
| 24 | regulation of immunoglobulin secretion (GO:0051023) | 3.94073392 |
| 25 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.90028291 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.89600607 |
| 27 | mature B cell differentiation (GO:0002335) | 3.88326436 |
| 28 | regulation of chemokine biosynthetic process (GO:0045073) | 3.84013121 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.83842977 |
| 30 | interferon-gamma production (GO:0032609) | 3.82133232 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.78147260 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.75236842 |
| 33 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.74898005 |
| 34 | leukocyte aggregation (GO:0070486) | 3.74181594 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.72284619 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.72284619 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.72284619 |
| 38 | kynurenine metabolic process (GO:0070189) | 3.71568318 |
| 39 | regulation of T-helper cell differentiation (GO:0045622) | 3.71401289 |
| 40 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.69249600 |
| 41 | positive regulation of interleukin-12 production (GO:0032735) | 3.64571649 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.63376589 |
| 43 | regulation of interleukin-12 production (GO:0032655) | 3.62323550 |
| 44 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.60676881 |
| 45 | regulation of mononuclear cell migration (GO:0071675) | 3.60462944 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60241977 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.58580775 |
| 48 | response to interleukin-15 (GO:0070672) | 3.56821988 |
| 49 | regulation of heat generation (GO:0031650) | 3.52293140 |
| 50 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.49432118 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47968975 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.47968975 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47968975 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47968975 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47968975 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 3.47968975 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.47837985 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.47837985 |
| 59 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.47041945 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 3.46794414 |
| 61 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.45858125 |
| 62 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.44411246 |
| 63 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.43675809 |
| 64 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43617937 |
| 65 | myeloid dendritic cell activation (GO:0001773) | 3.42206075 |
| 66 | lymph node development (GO:0048535) | 3.41136998 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.41116366 |
| 68 | cellular extravasation (GO:0045123) | 3.39056865 |
| 69 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.35776207 |
| 70 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.35692086 |
| 71 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.33944680 |
| 72 | regulation of type 2 immune response (GO:0002828) | 3.32687374 |
| 73 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.32423316 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.32367126 |
| 75 | activation of MAPKKK activity (GO:0000185) | 3.30578156 |
| 76 | positive regulation of defense response to virus by host (GO:0002230) | 3.30012151 |
| 77 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.28393356 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 3.26810916 |
| 79 | myeloid dendritic cell differentiation (GO:0043011) | 3.25347888 |
| 80 | cellular response to interferon-gamma (GO:0071346) | 3.24700705 |
| 81 | neutrophil activation (GO:0042119) | 3.23440403 |
| 82 | regulation of antigen processing and presentation (GO:0002577) | 3.21065658 |
| 83 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.20858269 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 3.20450595 |
| 85 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.20387561 |
| 86 | cellular response to interferon-alpha (GO:0035457) | 3.20083744 |
| 87 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.19838907 |
| 88 | response to type I interferon (GO:0034340) | 3.18445515 |
| 89 | germinal center formation (GO:0002467) | 3.17702009 |
| 90 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.17333700 |
| 91 | regulation of T-helper 1 type immune response (GO:0002825) | 3.16893931 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 3.15048762 |
| 93 | negative regulation of bone resorption (GO:0045779) | 3.13057210 |
| 94 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.11685715 |
| 95 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.11124618 |
| 96 | regulation of growth of symbiont in host (GO:0044126) | 3.11124618 |
| 97 | negative regulation of growth of symbiont in host (GO:0044130) | 3.11124618 |
| 98 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.11124618 |
| 99 | monocyte chemotaxis (GO:0002548) | 3.10427790 |
| 100 | cellular response to lipopolysaccharide (GO:0071222) | 3.10114466 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09122002 |
| 102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09081352 |
| 103 | granulocyte activation (GO:0036230) | 3.08945663 |
| 104 | negative regulation of amino acid transport (GO:0051956) | 3.08847498 |
| 105 | positive thymic T cell selection (GO:0045059) | 3.08614046 |
| 106 | response to interferon-gamma (GO:0034341) | 3.08133057 |
| 107 | T cell migration (GO:0072678) | 3.07043465 |
| 108 | megakaryocyte development (GO:0035855) | 3.06628164 |
| 109 | B cell homeostasis (GO:0001782) | 3.05278987 |
| 110 | type I interferon signaling pathway (GO:0060337) | 3.04876273 |
| 111 | cellular response to type I interferon (GO:0071357) | 3.04876273 |
| 112 | regulation of interferon-alpha production (GO:0032647) | 3.04662483 |
| 113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04546826 |
| 114 | regulation of RIG-I signaling pathway (GO:0039535) | 3.03903908 |
| 115 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.03561666 |
| 116 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.03552584 |
| 117 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02262133 |
| 118 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.01595488 |
| 119 | T-helper cell differentiation (GO:0042093) | 3.01595488 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.00918736 |
| 121 | leukocyte cell-cell adhesion (GO:0007159) | 3.00148334 |
| 122 | cellular response to nicotine (GO:0071316) | 2.99885113 |
| 123 | cellular response to molecule of bacterial origin (GO:0071219) | 2.99172173 |
| 124 | definitive hemopoiesis (GO:0060216) | 2.98957035 |
| 125 | negative regulation of lipid storage (GO:0010888) | 2.98576496 |
| 126 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97390831 |
| 127 | cellular response to exogenous dsRNA (GO:0071360) | 2.96864606 |
| 128 | hepatocyte apoptotic process (GO:0097284) | 2.96656472 |
| 129 | defense response to protozoan (GO:0042832) | 2.96328631 |
| 130 | cellular response to interferon-beta (GO:0035458) | 2.96287710 |
| 131 | lymphocyte chemotaxis (GO:0048247) | 2.96261250 |
| 132 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95731077 |
| 133 | cellular biogenic amine catabolic process (GO:0042402) | 2.95709033 |
| 134 | amine catabolic process (GO:0009310) | 2.95709033 |
| 135 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.94699426 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.94345075 |
| 137 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93960837 |
| 138 | positive regulation of acute inflammatory response (GO:0002675) | 2.93734032 |
| 139 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.93214342 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93147606 |
| 141 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.92269228 |
| 142 | negative regulation of granulocyte differentiation (GO:0030853) | 2.91936139 |
| 143 | tryptophan metabolic process (GO:0006568) | 2.91241996 |
| 144 | response to protozoan (GO:0001562) | 2.89259281 |
| 145 | lymphocyte homeostasis (GO:0002260) | 2.82614938 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80633212 |
| 147 | dendritic cell chemotaxis (GO:0002407) | 2.79751057 |
| 148 | dendritic cell differentiation (GO:0097028) | 2.79531060 |
| 149 | negative thymic T cell selection (GO:0045060) | 2.78564116 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.75906021 |
| 151 | positive regulation of heat generation (GO:0031652) | 2.74422215 |
| 152 | negative T cell selection (GO:0043383) | 2.73908492 |
| 153 | dendritic cell migration (GO:0036336) | 2.73806126 |
| 154 | T cell homeostasis (GO:0043029) | 2.73604379 |
| 155 | negative regulation of interleukin-12 production (GO:0032695) | 2.71933464 |
| 156 | response to peptidoglycan (GO:0032494) | 2.71844523 |
| 157 | myeloid cell activation involved in immune response (GO:0002275) | 2.69381100 |
| 158 | mast cell activation (GO:0045576) | 2.67181950 |
| 159 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66030195 |
| 160 | B cell mediated immunity (GO:0019724) | 2.65089415 |
| 161 | respiratory burst (GO:0045730) | 2.64935947 |
| 162 | T cell activation involved in immune response (GO:0002286) | 2.64040496 |
| 163 | angiogenesis involved in wound healing (GO:0060055) | 2.63865107 |
| 164 | regulation of erythrocyte differentiation (GO:0045646) | 2.63754561 |
| 165 | regulation of cell killing (GO:0031341) | 2.61998818 |
| 166 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.60645856 |
| 167 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.60645856 |
| 168 | T cell differentiation involved in immune response (GO:0002292) | 2.60645856 |
| 169 | regulation of mast cell activation (GO:0033003) | 2.60507104 |
| 170 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60423365 |
| 171 | leukocyte homeostasis (GO:0001776) | 2.59576349 |
| 172 | regulation of fever generation (GO:0031620) | 2.59530608 |
| 173 | positive regulation of interferon-beta production (GO:0032728) | 2.58138110 |
| 174 | positive regulation of B cell activation (GO:0050871) | 2.56773250 |
| 175 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56556275 |
| 176 | myeloid leukocyte activation (GO:0002274) | 2.56102703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.34270942 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.01532646 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.98055293 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.73955331 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76979552 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75434225 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.71928697 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.57388361 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34511594 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.29033404 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.17096107 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.14498784 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12912840 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94580251 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.73596042 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72537259 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.72401526 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72051595 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69583361 |
| 20 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67832399 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64739687 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.43528077 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.25149198 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23752848 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.21223906 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.20739310 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17769661 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16268016 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.15104271 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12886350 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10853760 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10382050 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03354887 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00297931 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99369196 |
| 36 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97740267 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88968983 |
| 38 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84864141 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83032212 |
| 40 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82926865 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81654425 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81046958 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80620623 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77197128 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.72439947 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70279047 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68141436 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66627233 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.66559821 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65354201 |
| 51 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59746863 |
| 52 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.56995165 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52889754 |
| 54 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52435844 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50802820 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49478527 |
| 57 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48169002 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44709728 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44568019 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.38452068 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37865304 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36492123 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33293219 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31799317 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.30269584 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29817647 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29108209 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26534978 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24173157 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23054219 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22151055 |
| 72 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19862567 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19758407 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18855593 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13908970 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12901960 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11935047 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09673054 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08929148 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07808880 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07280180 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06873941 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06080634 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05958373 |
| 85 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.05260387 |
| 86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04828376 |
| 87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01679399 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99777053 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97811287 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97665472 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96857925 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96640282 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95903603 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95482222 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94761742 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94575048 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94486579 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94346406 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94133849 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91873030 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91830882 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91103349 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90550069 |
| 104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86551519 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81986911 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80488679 |
| 107 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.79943699 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79611766 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77573013 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76803402 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75806936 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74849173 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73994214 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73927377 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72556877 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72556877 |
| 117 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72424374 |
| 118 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.71080820 |
| 119 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.71080820 |
| 120 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.71080820 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70997704 |
| 122 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67586612 |
| 123 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66438651 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.66128798 |
| 125 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65069991 |
| 126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64586445 |
| 127 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64135954 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63890595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.79894647 |
| 2 | MP0005671_abnormal_response_to | 3.19996143 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.19727247 |
| 4 | MP0000685_abnormal_immune_system | 3.14217970 |
| 5 | MP0003436_decreased_susceptibility_to | 3.09784187 |
| 6 | MP0001790_abnormal_immune_system | 3.08928724 |
| 7 | MP0005387_immune_system_phenotype | 3.08928724 |
| 8 | MP0009785_altered_susceptibility_to | 3.08067544 |
| 9 | MP0001800_abnormal_humoral_immune | 3.04747503 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.83618069 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.76526707 |
| 12 | MP0002723_abnormal_immune_serum | 2.67158097 |
| 13 | MP0002419_abnormal_innate_immunity | 2.60309828 |
| 14 | MP0005025_abnormal_response_to | 2.59382931 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.59036164 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.55564979 |
| 17 | MP0001819_abnormal_immune_cell | 2.54959727 |
| 18 | MP0003724_increased_susceptibility_to | 2.46391604 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.40022776 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.38412658 |
| 21 | MP0001873_stomach_inflammation | 2.36438879 |
| 22 | MP0003303_peritoneal_inflammation | 2.35549976 |
| 23 | MP0004510_myositis | 2.32283476 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.29284284 |
| 25 | MP0002398_abnormal_bone_marrow | 2.19492829 |
| 26 | MP0002405_respiratory_system_inflammati | 2.13567769 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.10946658 |
| 28 | MP0004947_skin_inflammation | 2.07215836 |
| 29 | MP0000716_abnormal_immune_system | 2.04303611 |
| 30 | MP0003866_abnormal_defecation | 2.03268484 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 2.00550626 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.95873336 |
| 33 | MP0003195_calcinosis | 1.94252007 |
| 34 | MP0006082_CNS_inflammation | 1.93904987 |
| 35 | MP0009278_abnormal_bone_marrow | 1.93652985 |
| 36 | MP0008004_abnormal_stomach_pH | 1.92325923 |
| 37 | MP0001853_heart_inflammation | 1.90792558 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.89201235 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.89201235 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.87890119 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.87486769 |
| 42 | MP0000490_abnormal_crypts_of | 1.82244223 |
| 43 | MP0005451_abnormal_body_composition | 1.81683709 |
| 44 | MP0002722_abnormal_immune_system | 1.81089847 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.77749341 |
| 46 | MP0002429_abnormal_blood_cell | 1.73347006 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.72630426 |
| 48 | MP0005310_abnormal_salivary_gland | 1.69157926 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.66416776 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.63244817 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.61759297 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.54403001 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.54350222 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.48018154 |
| 55 | MP0002933_joint_inflammation | 1.43775622 |
| 56 | MP0008469_abnormal_protein_level | 1.39217447 |
| 57 | MP0002006_tumorigenesis | 1.38987817 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.38560013 |
| 59 | MP0009764_decreased_sensitivity_to | 1.38247235 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.37719535 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.32201859 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.26984169 |
| 63 | MP0003690_abnormal_glial_cell | 1.23736106 |
| 64 | MP0000858_altered_metastatic_potential | 1.20556217 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.19363057 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.18534501 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.15854006 |
| 68 | MP0003448_altered_tumor_morphology | 1.14676850 |
| 69 | MP0000343_altered_response_to | 1.13269155 |
| 70 | MP0000604_amyloidosis | 1.12987533 |
| 71 | MP0002132_abnormal_respiratory_system | 1.12357476 |
| 72 | MP0003828_pulmonary_edema | 1.06494879 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.05821577 |
| 74 | MP0001851_eye_inflammation | 1.05117865 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.04086925 |
| 76 | MP0004147_increased_porphyrin_level | 1.02135604 |
| 77 | MP0001663_abnormal_digestive_system | 1.00319097 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.96346086 |
| 79 | MP0003646_muscle_fatigue | 0.96076575 |
| 80 | MP0005165_increased_susceptibility_to | 0.94959436 |
| 81 | MP0009840_abnormal_foam_cell | 0.94864038 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.90011253 |
| 83 | MP0005164_abnormal_response_to | 0.88539814 |
| 84 | MP0002163_abnormal_gland_morphology | 0.86109009 |
| 85 | MP0009763_increased_sensitivity_to | 0.86012032 |
| 86 | MP0005166_decreased_susceptibility_to | 0.85819989 |
| 87 | MP0006054_spinal_hemorrhage | 0.84428596 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.81249945 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.80385638 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.79898916 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 0.79261413 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.79016571 |
| 93 | MP0005535_abnormal_body_temperature | 0.78884875 |
| 94 | MP0000249_abnormal_blood_vessel | 0.78882717 |
| 95 | MP0005647_abnormal_sex_gland | 0.78752960 |
| 96 | MP0001542_abnormal_bone_strength | 0.78409394 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.78409125 |
| 98 | MP0010307_abnormal_tumor_latency | 0.76075956 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.75922466 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.72905076 |
| 101 | MP0005390_skeleton_phenotype | 0.70862468 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.70623385 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.69523145 |
| 104 | MP0003091_abnormal_cell_migration | 0.68998804 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.68137604 |
| 106 | MP0003795_abnormal_bone_structure | 0.67703457 |
| 107 | MP0002254_reproductive_system_inflammat | 0.67230419 |
| 108 | MP0002928_abnormal_bile_duct | 0.66959244 |
| 109 | MP0008874_decreased_physiological_sensi | 0.66611118 |
| 110 | MP0003075_altered_response_to | 0.66569221 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.65929461 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.65824408 |
| 113 | MP0005266_abnormal_metabolism | 0.65113064 |
| 114 | MP0001191_abnormal_skin_condition | 0.64878650 |
| 115 | MP0000920_abnormal_myelination | 0.64625048 |
| 116 | MP0000609_abnormal_liver_physiology | 0.64408275 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.63350011 |
| 118 | MP0005365_abnormal_bile_salt | 0.62290203 |
| 119 | MP0004043_abnormal_pH_regulation | 0.61138932 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.60461726 |
| 121 | MP0004782_abnormal_surfactant_physiolog | 0.59461408 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.59326018 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.59167258 |
| 124 | MP0003186_abnormal_redox_activity | 0.56968900 |
| 125 | MP0003045_fibrosis | 0.56867708 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.56274447 |
| 127 | MP0001764_abnormal_homeostasis | 0.55983811 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.53398602 |
| 129 | MP0004883_abnormal_blood_vessel | 0.53338747 |
| 130 | MP0005023_abnormal_wound_healing | 0.53102725 |
| 131 | MP0005448_abnormal_energy_balance | 0.51199619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.34110423 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.34110423 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.34110423 |
| 4 | Myositis (HP:0100614) | 5.55657086 |
| 5 | Optic neuritis (HP:0100653) | 4.95869157 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.95869157 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.94989049 |
| 8 | Orchitis (HP:0100796) | 4.85583072 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.72906296 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.52538951 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36939260 |
| 12 | Loss of speech (HP:0002371) | 4.30626746 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.30209234 |
| 14 | IgM deficiency (HP:0002850) | 4.07421682 |
| 15 | Disinhibition (HP:0000734) | 4.05384751 |
| 16 | Petechiae (HP:0000967) | 4.02506535 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.00876241 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.58368623 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.58368623 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.58368623 |
| 21 | Increased IgM level (HP:0003496) | 3.58134687 |
| 22 | Nuclear cataract (HP:0100018) | 3.56324983 |
| 23 | Vasculitis (HP:0002633) | 3.55229146 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.50742009 |
| 25 | Pustule (HP:0200039) | 3.49118181 |
| 26 | Recurrent viral infections (HP:0004429) | 3.47228018 |
| 27 | Mutism (HP:0002300) | 3.44639553 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.44503525 |
| 29 | Stomatitis (HP:0010280) | 3.40766276 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.38059457 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.38059457 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.34936696 |
| 33 | Colitis (HP:0002583) | 3.29831544 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.26795263 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.26520580 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26085438 |
| 37 | Recurrent skin infections (HP:0001581) | 3.24787446 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 3.24651042 |
| 39 | Parakeratosis (HP:0001036) | 3.23591644 |
| 40 | Tetraparesis (HP:0002273) | 3.20734659 |
| 41 | Meningitis (HP:0001287) | 3.17091813 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.14345602 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13613482 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13613482 |
| 45 | Gangrene (HP:0100758) | 3.12452265 |
| 46 | Chronic diarrhea (HP:0002028) | 3.12131652 |
| 47 | Pulmonary infiltrates (HP:0002113) | 3.11813488 |
| 48 | Thrombocytosis (HP:0001894) | 3.08603910 |
| 49 | Arterial thrombosis (HP:0004420) | 3.08051849 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00925515 |
| 51 | Keratoconjunctivitis (HP:0001096) | 2.96242891 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96023281 |
| 53 | Obstructive lung disease (HP:0006536) | 2.96023281 |
| 54 | Prostate neoplasm (HP:0100787) | 2.94969176 |
| 55 | Chronic otitis media (HP:0000389) | 2.93462057 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.92226319 |
| 57 | Abnormal platelet function (HP:0011869) | 2.92226319 |
| 58 | Cellulitis (HP:0100658) | 2.89271791 |
| 59 | Thyroiditis (HP:0100646) | 2.87427578 |
| 60 | Glomerulonephritis (HP:0000099) | 2.85574984 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.82451427 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.81218969 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.81087737 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.81015603 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.80819883 |
| 66 | Encephalitis (HP:0002383) | 2.80509109 |
| 67 | Epistaxis (HP:0000421) | 2.80123880 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.79412304 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.78790595 |
| 70 | Abnormality of T cell physiology (HP:0011840) | 2.75714762 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.74925715 |
| 72 | Abnormality of T cells (HP:0002843) | 2.74341336 |
| 73 | Hemoptysis (HP:0002105) | 2.73766424 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.73228625 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.70274371 |
| 76 | Gingival bleeding (HP:0000225) | 2.69986058 |
| 77 | Leukocytosis (HP:0001974) | 2.67224760 |
| 78 | Gingivitis (HP:0000230) | 2.66986776 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.66892751 |
| 80 | Joint swelling (HP:0001386) | 2.66492690 |
| 81 | Increased density of long bones (HP:0006392) | 2.65242266 |
| 82 | Increased serum ferritin (HP:0003281) | 2.64689700 |
| 83 | Osteomyelitis (HP:0002754) | 2.64612179 |
| 84 | Lymphopenia (HP:0001888) | 2.61056304 |
| 85 | Nausea (HP:0002018) | 2.59963382 |
| 86 | Periodontitis (HP:0000704) | 2.59895087 |
| 87 | Polyneuropathy (HP:0001271) | 2.58111332 |
| 88 | B lymphocytopenia (HP:0010976) | 2.55968652 |
| 89 | Abnormality of B cell number (HP:0010975) | 2.55968652 |
| 90 | Apathy (HP:0000741) | 2.53058638 |
| 91 | Nasal polyposis (HP:0100582) | 2.49538475 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49155565 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48866582 |
| 94 | T lymphocytopenia (HP:0005403) | 2.48781377 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.48701592 |
| 96 | Neurofibrillary tangles (HP:0002185) | 2.47508966 |
| 97 | Abnormality of T cell number (HP:0011839) | 2.46008585 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.45638641 |
| 99 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45561228 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 2.42968512 |
| 101 | Diminished motivation (HP:0000745) | 2.41693923 |
| 102 | Persistence of primary teeth (HP:0006335) | 2.41214378 |
| 103 | Severe combined immunodeficiency (HP:0004430) | 2.40272023 |
| 104 | Increased IgE level (HP:0003212) | 2.37291300 |
| 105 | IgA deficiency (HP:0002720) | 2.36850485 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.36660189 |
| 107 | Prolonged neonatal jaundice (HP:0006579) | 2.35877510 |
| 108 | Anorexia (HP:0002039) | 2.34888332 |
| 109 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.34752440 |
| 110 | Inappropriate behavior (HP:0000719) | 2.32874005 |
| 111 | Hematochezia (HP:0002573) | 2.31741740 |
| 112 | Abnormality of eosinophils (HP:0001879) | 2.29988933 |
| 113 | Metaphyseal irregularity (HP:0003025) | 2.28306255 |
| 114 | IgG deficiency (HP:0004315) | 2.26965079 |
| 115 | Axonal loss (HP:0003447) | 2.25894051 |
| 116 | Malnutrition (HP:0004395) | 2.25666294 |
| 117 | Poikilocytosis (HP:0004447) | 2.24876326 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 2.23613481 |
| 119 | Premature loss of primary teeth (HP:0006323) | 2.18630655 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 2.16437737 |
| 121 | Acanthocytosis (HP:0001927) | 2.15606062 |
| 122 | Combined immunodeficiency (HP:0005387) | 2.13975072 |
| 123 | Abnormal platelet volume (HP:0011876) | 2.13797169 |
| 124 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13592921 |
| 125 | Acne (HP:0001061) | 2.12549197 |
| 126 | Eosinophilia (HP:0001880) | 2.11848929 |
| 127 | Gastrointestinal infarctions (HP:0005244) | 2.11649396 |
| 128 | Urticaria (HP:0001025) | 2.11036151 |
| 129 | Purpura (HP:0000979) | 2.10702023 |
| 130 | Cheilitis (HP:0100825) | 2.10601622 |
| 131 | Granulocytopenia (HP:0001913) | 2.09373823 |
| 132 | Abnormality of the pericardium (HP:0001697) | 2.06869666 |
| 133 | Chest pain (HP:0100749) | 2.05974495 |
| 134 | Memory impairment (HP:0002354) | 2.05505957 |
| 135 | Recurrent pneumonia (HP:0006532) | 2.05296992 |
| 136 | Mesangial abnormality (HP:0001966) | 2.05000409 |
| 137 | Arthralgia (HP:0002829) | 2.04382446 |
| 138 | Recurrent sinusitis (HP:0011108) | 2.04133567 |
| 139 | Vertigo (HP:0002321) | 2.03727320 |
| 140 | Glomerulopathy (HP:0100820) | 2.03133136 |
| 141 | Amyloidosis (HP:0011034) | 2.02925844 |
| 142 | Complement deficiency (HP:0004431) | 2.01543850 |
| 143 | Autoimmune hemolytic anemia (HP:0001890) | 2.00317479 |
| 144 | Abnormality of the basal ganglia (HP:0002134) | 1.99317086 |
| 145 | Agnosia (HP:0010524) | 1.99119959 |
| 146 | Generalized aminoaciduria (HP:0002909) | 1.98377618 |
| 147 | Pulmonary embolism (HP:0002204) | 1.98255179 |
| 148 | Acute myeloid leukemia (HP:0004808) | 1.94884251 |
| 149 | Keratitis (HP:0000491) | 1.94236747 |
| 150 | Neuronal loss in central nervous system (HP:0002529) | 1.93492868 |
| 151 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.91541746 |
| 152 | Hepatosplenomegaly (HP:0001433) | 1.91506645 |
| 153 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91035238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.94854912 |
| 2 | MAP4K1 | 3.86373945 |
| 3 | TAOK3 | 3.46279515 |
| 4 | MAP3K14 | 3.36323235 |
| 5 | IRAK3 | 3.35430083 |
| 6 | TAOK2 | 2.97550109 |
| 7 | TBK1 | 2.82780580 |
| 8 | DDR2 | 2.69784158 |
| 9 | IKBKE | 2.56314404 |
| 10 | TGFBR2 | 2.45155855 |
| 11 | IRAK4 | 2.30931799 |
| 12 | TYK2 | 2.29386522 |
| 13 | TEC | 2.24887891 |
| 14 | IKBKB | 2.22096382 |
| 15 | KIT | 2.21258019 |
| 16 | JAK3 | 2.17260360 |
| 17 | TAOK1 | 2.17138897 |
| 18 | BTK | 2.03052006 |
| 19 | BMPR2 | 1.96313018 |
| 20 | RIPK4 | 1.95664323 |
| 21 | ZAP70 | 1.87035867 |
| 22 | ITK | 1.83423270 |
| 23 | MAP3K11 | 1.81748390 |
| 24 | BLK | 1.79974374 |
| 25 | JAK1 | 1.78137157 |
| 26 | SYK | 1.65963704 |
| 27 | STK10 | 1.62999586 |
| 28 | GRK6 | 1.62160040 |
| 29 | CHUK | 1.60023310 |
| 30 | FGR | 1.59634518 |
| 31 | MOS | 1.59315688 |
| 32 | PIM1 | 1.57508966 |
| 33 | IRAK1 | 1.45127821 |
| 34 | CSF1R | 1.38827145 |
| 35 | MAP2K3 | 1.36669279 |
| 36 | HCK | 1.35838143 |
| 37 | CDC42BPA | 1.32867589 |
| 38 | RPS6KA4 | 1.25681206 |
| 39 | PRPF4B | 1.23163894 |
| 40 | LCK | 1.22875879 |
| 41 | MAP3K13 | 1.21526026 |
| 42 | MATK | 1.15941129 |
| 43 | ERN1 | 1.15330965 |
| 44 | CSK | 1.13666446 |
| 45 | EPHB1 | 1.10409722 |
| 46 | LYN | 1.07650866 |
| 47 | SIK3 | 1.05637700 |
| 48 | MAP3K10 | 1.04639260 |
| 49 | ACVR1B | 1.04169799 |
| 50 | EEF2K | 1.02600168 |
| 51 | MST4 | 1.02386070 |
| 52 | IRAK2 | 1.01855596 |
| 53 | FGFR3 | 1.00068696 |
| 54 | NEK9 | 0.99805213 |
| 55 | PIM2 | 0.99356304 |
| 56 | MAP3K5 | 0.97492527 |
| 57 | MARK3 | 0.91269515 |
| 58 | MAP3K1 | 0.90318876 |
| 59 | JAK2 | 0.89799640 |
| 60 | NLK | 0.86120691 |
| 61 | ABL2 | 0.84885683 |
| 62 | FES | 0.84706972 |
| 63 | FLT3 | 0.84647023 |
| 64 | EPHA3 | 0.81832663 |
| 65 | PKN1 | 0.81655878 |
| 66 | FGFR4 | 0.81491300 |
| 67 | DAPK2 | 0.80669818 |
| 68 | TIE1 | 0.77230156 |
| 69 | PRKG2 | 0.76719927 |
| 70 | STK24 | 0.75065963 |
| 71 | CLK1 | 0.74498459 |
| 72 | DAPK3 | 0.74111254 |
| 73 | MAPK15 | 0.73829023 |
| 74 | TLK1 | 0.73463235 |
| 75 | SIK2 | 0.69713129 |
| 76 | CDK12 | 0.66138647 |
| 77 | TGFBR1 | 0.66119894 |
| 78 | PTK6 | 0.65168630 |
| 79 | MAP2K6 | 0.63609028 |
| 80 | DYRK3 | 0.62441572 |
| 81 | TRPM7 | 0.60429743 |
| 82 | CDK6 | 0.58755278 |
| 83 | RPS6KA6 | 0.58534378 |
| 84 | MAP3K12 | 0.56431184 |
| 85 | YES1 | 0.56073208 |
| 86 | PIK3CG | 0.55354581 |
| 87 | CDK9 | 0.55353721 |
| 88 | MAP3K7 | 0.55100944 |
| 89 | MAP3K3 | 0.54743828 |
| 90 | BRD4 | 0.54734953 |
| 91 | LRRK2 | 0.54164315 |
| 92 | MAP2K2 | 0.53005156 |
| 93 | BMX | 0.52914237 |
| 94 | LMTK2 | 0.52107187 |
| 95 | STK4 | 0.51634773 |
| 96 | SGK3 | 0.51395591 |
| 97 | CAMK1D | 0.50426953 |
| 98 | ADRBK2 | 0.48083295 |
| 99 | EIF2AK1 | 0.47934752 |
| 100 | MAPKAPK2 | 0.47891919 |
| 101 | GRK7 | 0.47792383 |
| 102 | EIF2AK2 | 0.46997714 |
| 103 | TYRO3 | 0.46842670 |
| 104 | PRKCQ | 0.45340738 |
| 105 | RIPK1 | 0.44063516 |
| 106 | TSSK6 | 0.43589716 |
| 107 | RPS6KC1 | 0.41399339 |
| 108 | RPS6KL1 | 0.41399339 |
| 109 | DYRK1B | 0.40069716 |
| 110 | NUAK1 | 0.39947907 |
| 111 | HIPK2 | 0.39628383 |
| 112 | PRKAA2 | 0.39375460 |
| 113 | NME2 | 0.38497614 |
| 114 | ABL1 | 0.38330453 |
| 115 | PDK1 | 0.36364492 |
| 116 | LATS2 | 0.36021809 |
| 117 | MAPK4 | 0.33992334 |
| 118 | SGK2 | 0.32920364 |
| 119 | EGFR | 0.29796893 |
| 120 | CDK4 | 0.28597350 |
| 121 | PRKCD | 0.28455622 |
| 122 | MAPK3 | 0.28287018 |
| 123 | FRK | 0.28043173 |
| 124 | RPS6KA2 | 0.27149541 |
| 125 | MAPK11 | 0.26895173 |
| 126 | INSR | 0.25465930 |
| 127 | RPS6KA5 | 0.19700066 |
| 128 | TESK1 | 0.16580957 |
| 129 | DAPK1 | 0.15164244 |
| 130 | TNK2 | 0.14129018 |
| 131 | CAMKK2 | 0.12394044 |
| 132 | FER | 0.11132007 |
| 133 | ARAF | 0.10875546 |
| 134 | MAP4K2 | 0.08663044 |
| 135 | MAPK7 | 0.08429158 |
| 136 | GSK3A | 0.07831495 |
| 137 | CAMK2G | 0.06964830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.15052308 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85769656 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83888863 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.74866627 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.61269626 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.52807480 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47415782 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.35920915 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.32397923 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.17181978 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06577025 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00349166 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99025782 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.88250380 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86636082 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84090496 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79138900 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.78935541 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76824034 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.69277142 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.67104017 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67075809 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65106005 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61996269 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61421697 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.60512917 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.52285269 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51022522 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.50185114 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.40121593 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39423552 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39022663 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35080068 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32518636 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31605152 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31256422 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.31037222 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.29494695 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29167312 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28233105 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.27644789 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.27363464 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23923638 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.13586880 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.12933955 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.12437275 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11377842 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06127094 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05982352 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.05209263 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00588851 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00455118 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98143418 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97819657 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94671495 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92837434 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91649456 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91050765 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84267502 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81614222 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.81153314 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80478127 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80250158 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78670428 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77248077 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.76401446 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.75414023 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73857435 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73722020 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70122095 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70031896 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64407645 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64360056 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64134995 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62881615 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61318391 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61212925 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61147023 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60836205 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60039194 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59921756 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59485084 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.59209190 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59016973 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52532519 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52521066 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52270979 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51802360 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51176886 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50866969 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50480597 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.46729103 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46037186 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44877229 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44730146 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44593619 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.44039717 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.43589196 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42932638 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42922112 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42843839 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42625669 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41602872 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41547895 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40913670 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39237964 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.36267266 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35822027 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35161225 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33363798 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29717268 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29115579 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.29007769 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28548412 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26295799 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19829142 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15945025 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.12988163 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09990259 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08177279 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.05363680 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.03327431 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01852292 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.01667336 |

